Table 1 |
|||||||
|
Dataset content from PrognoScan |
|||||||
|
Dataset |
Cancer type |
Subtype |
Cohort |
Author/Contributor |
Array type |
n |
Data source |
|
|
|||||||
|
GSE13507 |
Bladder cancer |
Transitional cell carcinoma |
Cheongju |
Kim |
Human-6 v2 |
n = 165 |
GEO |
|
GSE5287 |
Bladder cancer |
Aarhus (1995–2004) |
Als et al. [10] |
HG-U133A |
n = 30 |
GEO |
|
|
GSE12417-GPL570 |
Blood cancer |
AML |
AMLCG (2004) |
Metzeler et al. [11] |
HG-U133_Plus_2 |
n = 79 |
GEO |
|
GSE12417-GPL96 |
Blood cancer |
AML |
AMLCG (1999–2003) |
Metzeler et al. [11] |
HG-U133A |
n = 163 |
GEO |
|
GSE12417-GPL97 |
Blood cancer |
AML |
AMLCG (1999–2003) |
Metzeler et al. [11] |
HG-U133B |
n = 163 |
GEO |
|
GSE8970 |
Blood cancer |
AML |
San Diego |
Raponi et al. [12] |
HG-U133A |
n = 34 |
GEO |
|
GSE4475 |
Blood cancer |
B-cell lymphoma |
Berlin (2003–2005) |
Hummel et al. [13] |
HG-U133A |
n = 158 |
GEO |
|
E-TABM-346 |
Blood cancer |
DLBCL |
GELA (1998–2000) |
Jais et al. [14] |
HG-U133A |
n = 53 |
ArrayExpress |
|
GSE2658 |
Blood cancer |
Multiple myeloma |
Arkansas |
Zhan et al. [15] |
HG-U133_Plus_2 |
n = 559 |
GEO |
|
E-TABM-158 |
Breast cancer |
UCSF, CPMC (1989–1997) |
Chin et al. [16] |
HG-U133A |
n = 129 |
ArrayExpress |
|
|
GSE11121 |
Breast cancer |
Mainz (1988–1998) |
Schmidt et al. [17] |
HG-U133A |
n = 200 |
GEO |
|
|
GSE1378 |
Breast cancer |
MGH (1987–2000) |
Ma et al. [18] |
Arcturus 22 k |
n = 60 |
GEO |
|
|
GSE1379 |
Breast cancer |
MGH (1987–2000) |
Ma et al. [18] |
Arcturus 22 k |
n = 60 |
GEO |
|
|
GSE1456-GPL96 |
Breast cancer |
Stockholm (1994–1996) |
Pawitan et al. [19] |
HG-U133A |
n = 159 |
GEO |
|
|
GSE1456-GPL97 |
Breast cancer |
Stockholm (1994–1996) |
Pawitan et al. [19] |
HG-U133B |
n = 159 |
GEO |
|
|
GSE2034 |
Breast cancer |
Rotterdam (1980–1995) |
Wang et al. [20] |
HG-U133A |
n = 286 |
GEO |
|
|
GSE2990 |
Breast cancer |
Uppsala, Oxford |
Sotiriou et al. [21] |
HG-U133A |
n = 187 |
GEO |
|
|
GSE3143 |
Breast cancer |
Duke |
Bild et al. [22] |
HG-U95A |
n = 158 |
GEO |
|
|
GSE3494-GPL96 |
Breast cancer |
Uppsala (1987–1989) |
Miller et al. [23] |
HG-U133A |
n = 236 |
GEO |
|
|
GSE3494-GPL97 |
Breast cancer |
Uppsala (1987–1989) |
Miller et al. [23] |
HG-U133B |
n = 236 |
GEO |
|
|
GSE4922-GPL96 |
Breast cancer |
Uppsala (1987–1989) |
Ivshina et al. [24] |
HG-U133A |
n = 249 |
GEO |
|
|
GSE4922-GPL97 |
Breast cancer |
Uppsala (1987–1989) |
Ivshina et al. [24] |
HG-U133B |
n = 249 |
GEO |
|
|
GSE6532-GPL570 |
Breast cancer |
GUYT |
Loi et al. [25] |
HG-U133_Plus_2 |
n = 87 |
GEO |
|
|
GSE7378 |
Breast cancer |
UCSF |
Zhou et al. [26] |
U133AAofAv2 |
n = 54 |
GEO |
|
|
GSE7390 |
Breast cancer |
Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980–1998) |
Desmedt et al. [27] |
HG-U133A |
n = 198 |
GEO |
|
|
GSE7849 |
Breast cancer |
Duke (1990–2001) |
Anders et al. [28] |
HG-U95A |
n = 76 |
GEO |
|
|
GSE9195 |
Breast cancer |
GUYT2 |
Loi et al. [25] |
HG-U133_Plus_2 |
n = 77 |
GEO |
|
|
GSE9893 |
Breast cancer |
Montpellier, Bordeaux, Turin (1989–2001) |
Chanrion et al. [29] |
MLRG Human 21 K V12.0 |
n = 155 |
GEO |
|
|
GSE11595 |
Esophagus cancer |
Adenocarcinoma |
Sutton |
Giddings |
CRUKDMF_22 K_v1.0.0 |
n = 34 |
GEO |
|
GSE7696 |
Glioma |
Glioblastoma |
Lausanne |
Murat et al. [30] |
HG-U133_Plus_2 |
n = 70 |
GEO |
|
GSE4271-GPL96 |
Glioma |
MDA |
Phillips et al. [31] |
HG-U133A |
n = 77 |
GEO |
|
|
GSE4271-GPL97 |
Glioma |
MDA |
Phillips et al. [31] |
HG-U133B |
n = 77 |
GEO |
|
|
GSE2837 |
Head and neck cancer |
Squamous cell carcinoma |
VUMC, VAMC, UTMDACC (1992–2005) |
Chung et al. [32] |
U133_X3P |
n = 28 |
GEO |
|
HARVARD-LC |
Lung cancer |
Adenocarcinoma |
Harvard |
Beer et al. [33] |
HG-U95A |
n = 84 |
Author's web site |
|
MICHIGAN-LC |
Lung cancer |
Adenocarcinoma |
Michigan (1994–2000) |
Beer et al. [33] |
HuGeneFL |
n = 86 |
Author's web site |
|
GSE11117 |
Lung cancer |
NSCLC |
Basel |
Baty |
Novachip human 34.5 k |
n = 41 |
GEO |
|
GSE3141 |
Lung cancer |
NSCLC |
Duke |
Bild et al. [22] |
HG-U133_Plus_2 |
n = 111 |
GEO |
|
GSE4716-GPL3694 |
Lung cancer |
NSCLC |
Nagoya (1995–1996) |
Tomida et al. [34] |
GF200 |
n = 50 |
GEO |
|
GSE4716-GPL3696 |
Lung cancer |
NSCLC |
Nagoya (1995–1996) |
Tomida et al. [34] |
GF201 |
n = 50 |
GEO |
|
GSE8894 |
Lung cancer |
NSCLC |
Seoul |
Son |
HG-U133_Plus_2 |
n = 138 |
GEO |
|
GSE4573 |
Lung cancer |
Squamous cell carcinoma |
Michigan (1991–2002) |
Raponi et al. [35] |
HG-U133A |
n = 129 |
GEO |
|
DUKE-OC |
Ovarian cancer |
Duke |
Bild et al. [22] |
HG-U133A |
n = 134 |
Author's web site |
|
|
GSE8841 |
Ovarian cancer |
Milan |
Mariani |
G4100A |
n = 83 |
GEO |
|
|
E-DKFZ-1 |
Renal cell carcinoma |
RZPD |
Sueltmann |
A-RZPD-20 |
n = 74 |
ArrayExpress |
|
|
|
|||||||
|
Abbreviations: AML, Acute myelocytic leukemia; DLBCL, Diffuse large B-cell lymphoma; NSCLC, Non-small cell lung cancer |
|||||||
|
Mizuno et al. BMC Medical Genomics 2009 2:18 doi:10.1186/1755-8794-2-18 |
|||||||
